AKT1 and colorectal carcinoma: Our results confirmed that ZDQ-0620 inhibits the migration, invasion, and angiogenesis of CRC cells, which may be related to a decrease in AKT phosphorylation levels or inhibit the secretion of chemokines, such as VEGF.